Literature DB >> 16087856

Choroidal infarction following photodynamic therapy with verteporfin.

Christina M Klais1, Michael D Ober, K Bailey Freund, Leonard H Ginsburg, Alan Luckie, Martine Mauget-Faÿsse, Gabriel Coscas, Nicole E Gross, Lawrence A Yannuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16087856     DOI： 10.1001/archopht.123.8.1149

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  19 in total

1.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Capillary dropout after photodynamic therapy in a patient with Bechet's disease.

Authors:  Ke-Hung Chien; Yun-Hsiang Chang; Ching-Long Chen; Jiann-Torng Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-12       Impact factor: 3.117

3.  A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agents.

Authors:  Mark C Butler; Patrick N Itotia; Jack M Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

4.  Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Chun-Fu Liu; Lee-Jen Chen; Shawn H Tsai; Chi-Chun Lai; Wei-Chun Chan; Wei-Chi Wu; Nan-Kai Wang; Kuan-Jen Chen; Yih-Shiou Hwang; Yen-Po Chen; Ling Yeung
Journal:  J Ocul Pharmacol Ther       Date:  2014-03-05       Impact factor: 2.671

Review 5.  Genetic predictors of response to photodynamictherapy.

Authors:  Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Francesco Semeraro; Paolo Perri; Sergio D'Angelo; Mario R Romano; Katia De Nadai; Adolfo Sebastiani; Carlo Incorvaia
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

6.  Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation.

Authors:  Alexandros A Rouvas; Thanos D Papakostas; Ioannis D Ladas; Ioannis Vergados
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-24       Impact factor: 3.117

7.  Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.

Authors:  S J Kang; I Schmack; H E Benson; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

8.  Chorioretinal anastomosis after photodynamic therapy for polypoidal choroidal vasculopathy: CRA after PDT for PCV.

Authors:  Yuko Yodoi; Akitaka Tsujikawa; Atsushi Otani; Hiroko Aikawa; Nagahisa Yoshimura
Journal:  Int Ophthalmol       Date:  2007-08-15       Impact factor: 2.031

9.  Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography.

Authors:  Hideki Koizumi; Tomohiro Iida; Masaaki Saito; Dai Nagayama; Ichiro Maruko
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-31       Impact factor: 3.117

10.  Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia.

Authors:  Kyoko Ohno-Matsui; Muka Moriyama; Kengo Hayashi; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.